Lumawas, Retchel .

HRN: 29-41-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2026
CEFUROXIME 500MG (TAB)
08/07/2026
08/14/2026
PO
500 Mg
BID
TMSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: